Want to join the conversation?
$MRK 2Q15 Call: Joe Romanelli has been appointed as Merck’s Managing Director for business in Taiwan and Hong Kong. Global Human Health delivered top line growth in four core areas of Oncology, Hospital Acute Care, Diabetes and Vaccines. Animal Health business also grew 10% due in part to the strong growth of BRAVECTO.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?